These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Amino acid substitutions at the major insertion loop of Candida albicans sterol 14alpha-demethylase are involved in fluconazole resistance. Alvarez-Rueda N, Fleury A, Morio F, Pagniez F, Gastinel L, Le Pape P. PLoS One; 2011; 6(6):e21239. PubMed ID: 21698128 [Abstract] [Full Text] [Related]
23. Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450. Asai K, Tsuchimori N, Okonogi K, Perfect JR, Gotoh O, Yoshida Y. Antimicrob Agents Chemother; 1999 May; 43(5):1163-9. PubMed ID: 10223930 [Abstract] [Full Text] [Related]
24. Structural basis of human CYP51 inhibition by antifungal azoles. Strushkevich N, Usanov SA, Park HW. J Mol Biol; 2010 Apr 09; 397(4):1067-78. PubMed ID: 20149798 [Abstract] [Full Text] [Related]
25. Aspergillus fumigatus CYP51 sequence: potential basis for fluconazole resistance. Edlind TD, Henry KW, Metera KA, Katiyar SK. Med Mycol; 2001 Jun 09; 39(3):299-302. PubMed ID: 11446535 [Abstract] [Full Text] [Related]
26. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding. Xiao L, Madison V, Chau AS, Loebenberg D, Palermo RE, McNicholas PM. Antimicrob Agents Chemother; 2004 Feb 09; 48(2):568-74. PubMed ID: 14742211 [Abstract] [Full Text] [Related]
27. Optimized expression and catalytic properties of a wheat obtusifoliol 14alpha-demethylase (CYP51) expressed in yeast. Complementation of erg11Delta yeast mutants by plant CYP51. Cabello-Hurtado F, Taton M, Forthoffer N, Kahn R, Bak S, Rahier A, Werck-Reichhart D. Eur J Biochem; 1999 Jun 09; 262(2):435-46. PubMed ID: 10336628 [Abstract] [Full Text] [Related]
28. Molecular modelling of lanosterol 14 alpha-demethylase (CYP51) from Saccharomyces cerevisiae via homology with CYP102, a unique bacterial cytochrome P450 isoform: quantitative structure-activity relationships (QSARs) within two related series of antifungal azole derivatives. Lewis DF, Wiseman A, Tarbit MH. J Enzyme Inhib; 1999 Jun 09; 14(3):175-92. PubMed ID: 10445042 [Abstract] [Full Text] [Related]
29. Cloning and characterization of CYP51 from Mycobacterium avium. Pietila MP, Vohra PK, Sanyal B, Wengenack NL, Raghavakaimal S, Thomas CF. Am J Respir Cell Mol Biol; 2006 Aug 09; 35(2):236-42. PubMed ID: 16543605 [Abstract] [Full Text] [Related]
30. An old activity in the cytochrome P450 superfamily (CYP51) and a new story of drugs and resistance. Kelly SL, Lamb DC, Cannieux M, Greetham D, Jackson CJ, Marczylo T, Ugochukwu C, Kelly DE. Biochem Soc Trans; 2001 May 09; 29(Pt 2):122-8. PubMed ID: 11356139 [Abstract] [Full Text] [Related]
31. Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains. Löffler J, Kelly SL, Hebart H, Schumacher U, Lass-Flörl C, Einsele H. FEMS Microbiol Lett; 1997 Jun 15; 151(2):263-8. PubMed ID: 9228762 [Abstract] [Full Text] [Related]
32. Conservation in the CYP51 family. Role of the B' helix/BC loop and helices F and G in enzymatic function. Lepesheva GI, Virus C, Waterman MR. Biochemistry; 2003 Aug 05; 42(30):9091-101. PubMed ID: 12885242 [Abstract] [Full Text] [Related]
33. Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14α-Demethylase. Sagatova AA, Keniya MV, Wilson RK, Monk BC, Tyndall JD. Antimicrob Agents Chemother; 2015 Aug 05; 59(8):4982-9. PubMed ID: 26055382 [Abstract] [Full Text] [Related]
34. CYP51 from Trypanosoma brucei is obtusifoliol-specific. Lepesheva GI, Nes WD, Zhou W, Hill GC, Waterman MR. Biochemistry; 2004 Aug 24; 43(33):10789-99. PubMed ID: 15311940 [Abstract] [Full Text] [Related]
35. Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa. Warrilow AG, Price CL, Parker JE, Rolley NJ, Smyrniotis CJ, Hughes DD, Thoss V, Nes WD, Kelly DE, Holman TR, Kelly SL. Sci Rep; 2016 Jun 13; 6():27690. PubMed ID: 27291783 [Abstract] [Full Text] [Related]
36. Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans. Favre B, Didmon M, Ryder NS. Microbiology (Reading); 1999 Oct 13; 145 ( Pt 10)():2715-25. PubMed ID: 10537193 [Abstract] [Full Text] [Related]
37. Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens. Warrilow AG, Parker JE, Kelly DE, Kelly SL. Antimicrob Agents Chemother; 2013 Mar 13; 57(3):1352-60. PubMed ID: 23274672 [Abstract] [Full Text] [Related]
38. The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance. Alvarez-Rueda N, Fleury A, Logé C, Pagniez F, Robert E, Morio F, Le Pape P. Med Mycol; 2016 Oct 01; 54(7):764-775. PubMed ID: 27143634 [Abstract] [Full Text] [Related]
39. X-ray structure of 4,4'-dihydroxybenzophenone mimicking sterol substrate in the active site of sterol 14alpha-demethylase (CYP51). Eddine AN, von Kries JP, Podust MV, Warrier T, Kaufmann SH, Podust LM. J Biol Chem; 2008 May 30; 283(22):15152-9. PubMed ID: 18367444 [Abstract] [Full Text] [Related]
40. Estriol bound and ligand-free structures of sterol 14alpha-demethylase. Podust LM, Yermalitskaya LV, Lepesheva GI, Podust VN, Dalmasso EA, Waterman MR. Structure; 2004 Nov 30; 12(11):1937-45. PubMed ID: 15530358 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]